Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Munder

Showing results (11-20 of 88) with videos related to

Pageof 9
Sort By:
Journal of Clinical Medicine|January 23, 2024
Does Systemic Hematological Therapy Influence the Course of Paraproteinemic Keratopathy?Mohammad Al Hariri, Markus Munder, Norbert Pfeiffer, et al.
Plos One|November 16, 2012
Characterization of a novel population of low-density granulocytes associated with disease severity in HIV-1 infectionThomas Cloke, Markus Munder, Graham Taylor, et al.
Frontiers in Immunology|December 25, 2014
Macrophage: SHIP of ImmunityCharles D Mills, Anita C Thomas, Laurel L Lenz, et al.
Frontiers in Immunology|November 12, 2014
Metabolism via Arginase or Nitric Oxide Synthase: Two Competing Arginine Pathways in MacrophagesMeera Rath, Ingrid Müller, Pascale Kropf, et al.
Haematologica|July 1, 2021
Novel immunotherapies in multiple myeloma - chances and challengesLeo Rasche, Ralph Wäsch, Markus Munder, et al.
BMC Cancer|April 16, 2020
Challenges in the cultural adaptation of the German Myeloma Patient Outcome Scale (MyPOS): an outcome measure to support routine symptom assessment in myeloma careChristina Gerlach, Katherine Taylor, Marion Ferner, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 16, 2006
Highly efficient expansion of human CD4+CD25+ regulatory T cells for cellular immunotherapy in patients with graft-versus-host diseaseSvetlana Karakhanova, Markus Munder, Markus Schneider, et al.
Cells|January 30, 2020
Identification of Novel Rare <i>ABCC1</i> Transporter Mutations in Tumor Biopsies of Cancer PatientsOnat Kadioglu, Mohamed Saeed, Markus Munder, et al.
Annual Review of Immunology|February 28, 2002
T cell response in experimental autoimmune encephalomyelitis (EAE): role of self and cross-reactive antigens in shaping, tuning, and regulating the autopathogenic T cell repertoireVijay K Kuchroo, Ana C Anderson, Hanspeter Waldner, et al.
The Journal of Experimental Medicine|November 6, 2002
Reduced self-reactivity of an autoreactive T cell after activation with cross-reactive non-self-ligandMarkus Munder, Estelle Bettelli, Laurent Monney, et al.
Pageof 9

Showing results (11-20 of 88) with videos related to

Sort By:
Pageof 9
Journal of Clinical Medicine|January 23, 2024
Does Systemic Hematological Therapy Influence the Course of Paraproteinemic Keratopathy?Mohammad Al Hariri, Markus Munder, Norbert Pfeiffer, et al.
Plos One|November 16, 2012
Characterization of a novel population of low-density granulocytes associated with disease severity in HIV-1 infectionThomas Cloke, Markus Munder, Graham Taylor, et al.
Frontiers in Immunology|December 25, 2014
Macrophage: SHIP of ImmunityCharles D Mills, Anita C Thomas, Laurel L Lenz, et al.
Frontiers in Immunology|November 12, 2014
Metabolism via Arginase or Nitric Oxide Synthase: Two Competing Arginine Pathways in MacrophagesMeera Rath, Ingrid Müller, Pascale Kropf, et al.
Haematologica|July 1, 2021
Novel immunotherapies in multiple myeloma - chances and challengesLeo Rasche, Ralph Wäsch, Markus Munder, et al.
BMC Cancer|April 16, 2020
Challenges in the cultural adaptation of the German Myeloma Patient Outcome Scale (MyPOS): an outcome measure to support routine symptom assessment in myeloma careChristina Gerlach, Katherine Taylor, Marion Ferner, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 16, 2006
Highly efficient expansion of human CD4+CD25+ regulatory T cells for cellular immunotherapy in patients with graft-versus-host diseaseSvetlana Karakhanova, Markus Munder, Markus Schneider, et al.
Cells|January 30, 2020
Identification of Novel Rare <i>ABCC1</i> Transporter Mutations in Tumor Biopsies of Cancer PatientsOnat Kadioglu, Mohamed Saeed, Markus Munder, et al.
Annual Review of Immunology|February 28, 2002
T cell response in experimental autoimmune encephalomyelitis (EAE): role of self and cross-reactive antigens in shaping, tuning, and regulating the autopathogenic T cell repertoireVijay K Kuchroo, Ana C Anderson, Hanspeter Waldner, et al.
The Journal of Experimental Medicine|November 6, 2002
Reduced self-reactivity of an autoreactive T cell after activation with cross-reactive non-self-ligandMarkus Munder, Estelle Bettelli, Laurent Monney, et al.
Pageof 9